Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
AIDS Reviews|March 23, 2019
A Model for Potential B-cell Precursors of Broadly Neutralizing HIV-1 Antibodies Selection and Antibody Affinity MaturationRadmila Metlas, Tatjana Srdic-Rajic
Immunology Letters|November 17, 2021
Antibody VH domain sequence analysis by a bioinformatics approach based on electronic amino acid properties may help to predict paratop locationTatjana Srdic-Rajic, Radmila Metlas
Anti-Cancer Agents in Medicinal Chemistry|May 19, 2026
Computational Design, Synthesis, and In Vitro Evaluation of Novel Piperazine-Based HDAC Inhibitors as Potential Breast Cancer TherapeuticsSehija Dizdarevic, Dusan Ruzic, Tatjana Srdic-Radic, et al.
Frontiers in Immunology|November 9, 2018
Antibody Epitope Specificity for dsDNA Phosphate Backbone Is an Intrinsic Property of the Heavy Chain Variable Germline Gene Segment UsedTatjana Srdic-Rajic, Heinz Kohler, Vladimir Jurisic, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Clinical stage-depending decrease of NK cell activity in multiple myeloma patientsVladimir Jurisic, Tatjana Srdic, Gordana Konjevic, et al.
Annals of Hematology|November 2, 2005
Effect of TNF-alpha on Raji cells at different cellular levels estimated by various methodsVladimir Jurisic, Gordana Bogdanovic, Vesna Kojic, et al.
The Journal of Membrane Biology|January 12, 2011
TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cellsVladimir Jurisic, Tatjana Srdic-Rajic, Gordana Konjevic, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic CarcinomaNemanja Djokovic, Ana Djuric, Dusan Ruzic, et al.
Combinatorial Chemistry & High Throughput Screening|January 31, 2013
Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking studyKatarina Nikolic, Nevena Veljkovic, Branislava Gemovic, et al.
Journal of Hepatocellular Carcinoma|July 27, 2017
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategiesDanijel Galun, Tatjana Srdic-Rajic, Aleksandar Bogdanovic, et al.
Pageof 3